First Transcatheter Tricuspid Regurgitation Treatment Approved

(MedPage Today) -- The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for severe TR that is symptomatic...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news